In focus
Latest feed
Cytokinetics' Myqorzo Secures Landmark FDA Approval, Reshaping HCM Treatment Landscape
Navigating the Nuances of Cytokinetics: December's Catalyst and the Investment Conundrum
A Brewing Storm: Cytokinetics Investors Face Critical Choices as Legal Action Looms
The Unseen Pulse: How Cytokinetics is Quietly Reshaping the Future of Heart Health
